Today’s analyst estimates for ZYXI of $20.47 (Sentieo) are more than 185% higher than ZYXI’s current price of $7.00, a price that we think might represent a “coming back down to earth” scenario, where valuation should be reassessed, even in light of a new February 17, 2022 report by Night Market Research on the company titled, “Zynex: UnitedHealthcare Terminating Contract – An Undisclosed Loss That Accounts For 50%+ EBITDA.”

Night Market Research thinks that guidance will need to be dropped, but is this really the case? Will the UnitedHealthcare Network want to get back money for which they were supposedly overbilled, or will they have already lost their leverage and window of opportunity, being that they were originally part of Zynex’s network? Will the new acquisition dilute shareholders since more than half of it was stock-based, and how accretive will it be? How will this affect estimates?

On this Super Bowl Sunday, we’re highlighting a PodClip recorded by Maj on Friday where he talks about a few things.  First he reflects upon his investing over the years and how the market is rotational. After years of reckless behavior where investors ignored, valuations came into play and the numbers matter again – microcaps being a big beneficiary of this pattern of capitulation and resetting.

Origin Agritech Limited (NASDAQ:SEED) filed its 20F after the close last Friday. We are obviously not pleased with the company’s propensity to overpromise and underdeliver. However, a lot of this has to do with the government delaying the GMO positive process that appeared to be a goal that should have been met by the end of 2021, according to information published on various sources in China.

Nonetheless, we still think that Dr. Gengchen Han, the chairman and founder of the company, needs to step up to the plate and buy stock in the open market to help instill investor confidence in the company’s future.

There’s been a retail investor exodus from the markets, as is evidenced by Robin Hood’s disclosure of a widespread disengagement of its users over the past 2 quarters. Could it be that the existence of a vastly inexperienced and isolated investor base has finally manifested itself as a situation where the first sign of market turmoil turns into a flight to safety? How many have been irreversibly monetarily affected, in turn causing a disaffected state of mind? After all, 2020 to 2021 saw the biggest influx of retail investors in history, over 10 million.

Since 2010, there’s really been this disconnect in the market. A lot of high flying stocks, with high growth rates and revenue with perhaps little earnings per share growth or maybe even negative cash flow, had risen to nosebleed valuations in terms of prices to sales and enterprise value to sales ratios. You can’t value them on other metrics, really. Some of them might have weak balance sheets, using debt and leverage to grow their revenue.

Welcome to The GeoWire As we enter the next week and in case you missed it, we wanted to reiterate the Call To Action that was put out on a technology stock that was originally in our FundiTrading Model Portfolio. […]

Happy New Year! With another year down the drain, we looked back at some of the things that we embarked upon in 2021, as well as some of the recurring subject matter that we tracked during each passing month. It’s likely that a good deal of coverage is going to bleed into 2022, but our pipeline of new stock ideas is always robust and on the immediate horizon,